LKC Technologies specializes in advanced diagnostic solutions for assessing retinal function in both humans and animals. Their flagship products include the RETeval® device, a portable, FDA-cleared electroretinography (ERG) and visual evoked potential (VEP) testing device that operates without the need for pupil dilation. This device is designed to provide objective data that aids in the diagnosis and management of various retinal conditions, such as diabetic retinopathy and glaucoma. Additionally, LKC offers the RETevet™ device tailored for veterinary ophthalmologists, allowing real-time measurement of an animal's retinal function. Their UTAS product line, including the SunBurst™ and BigShot™, supports a range of electrophysiological tests, ensuring compliance with international standards while maintaining user-friendly interfaces.

The technologies developed by LKC Technologies are pivotal in enhancing clinical practices by enabling efficient monitoring of disease progression and treatment outcomes. Their systems facilitate comprehensive research into retinal function, providing clinicians and researchers with accurate and repeatable results. By integrating these advanced diagnostic tools into their practices, healthcare professionals can achieve superior patient outcomes and gain deeper insights into the factors affecting visual pathways and retinal health.

United States

For 45+ years, LKC Technologies has been making functional eye testing simple and practical for busy clinicians. The handheld, portable RETeval® ERG/VEP device aids in the diagnosis and management of ischemic conditions such as diabetic retinopathy, optic nerve conditions, and other retinal dystrophies by providing objective results without corneal contact.

LKC Technologies

Company Details